IMPACT OF RECENT BENDAMUSTINE (BENDA) EXPOSURE IN PATIENTS (PTS) WITH RELPASED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) TREATED WITH ODRONEXTAMAB (ODRO) IN THE PHASE 2 ELM-2 STUDY

EHA Library, Gloria Iacoboni, 4208592

COMPARATIVE EFFECTIVENESS OF EPCORITAMAB, LENALIDOMIDE, AND RITUXIMAB IN EPCORE FL-1 VS REAL-WORLD CHEMOIMMUNOTHERAPY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

EHA Library, Lorenzo Falchi, 4208593

CELESTIMO SINGLE ARM EXTENSION: SAFETY AND EFFICACY OF MOSUNETUZUMAB PLUS LENALIDOMIDE IN PATIENTS WITH R/R FOLLICULAR LYMPHOMA

EHA Library, L. Elizabeth Budde, 4208594

REAL-WORLD OUTCOMES OF BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

EHA Library, Rahul Shah, 4208596

REAL-WORLD EPIDEMIOLOGY TRENDS AND SURVIVAL CHARACTERISTICS OF EXTRANODAL MARGINAL ZONE LYMPHOMA BY ANATOMICAL SUBTYPE IN ENGLAND FROM 2014-2022: FINDINGS FROM THE UNCOVER STUDY PROGRAMME.

EHA Library, Li Yuan Chan, 4208598

CD19-DIRRECTED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: OFF-TRIAL OUTCOMES AND SUBSEQUENT THERAPY

EHA Library, Alfredo Rivas-Delgado, 4208602

COMPARATIVE ANALYSES OF EPCORITAMAB IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB VS OBINUTUZUMAB AND BENDAMUSTINE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

EHA Library, Johannes Duell, 4208603

IBRUTINIB IN SECOND-LINE RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE SECOND INTERIM ANALYSIS OF THE OLIMPUS STUDY

EHA Library, Carlo Visco, 4208612

PROFILING THE CSF-CTDNA MUTATIONAL LANDSCAPE IN A LARGE COHORT OF DLBCL: IMPLICATIONS FOR PREDICTING CNS RELAPSE AND CLINICAL OUTCOMES

EHA Library, Jinhua Liang, 4208613

DURABLE REMISSIONS WITH GLOFITAMAB PLUS POLATUZUMAB VEDOTIN IN RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL), INCLUDING ELDERLY PATIENTS AND THOSE WITH HIGH-GRADE B-CELL LYMPHOMA (HGBCL)

EHA Library, Giuseppe Gritti, 4208614

SELINEXOR IN COMBINATION WITH THE R-CHOP REGIMEN AS A FIRST-LINE TREATMENT FOR PATIENTS WITH HIGH-RISK GCB-SUBTYPE DIFFUSE LARGE B-CELL LYMPHOMA: A MULTI-CENTER, SINGLE-ARM, PHASE II STUDY

EHA Library, Zhiming Li, 4208616

A PHASE 1 STUDY OF KITE-753 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL LYMPHOMA: UPDATED SAFETY AND EFFICACY RESULTS

EHA Library, Sairah Ahmed, 4208619

IMPACT OF TP53 MUTATION ON CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN LARGE B-CELL LYMPHOMA

EHA Library, Lingshuang Sheng, 4208622

ANTIANGIOGENIC TREATMENT OF PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA - EXPERIENCE OF A HUNGARIAN CENTER

EHA Library, Boglarka Csilla Brugos, 4209016

ISTH BLEEDING SCORE (ISTH-BAT) IN DIAGNOSTIC PROFILE OF BLEEDING PATIENTS RELATED TO SCORING IN CLINICAL DIAGNOSIS PRACTICE 2015-2025 IN TWO CENTRES IN ESTONIA

EHA Library, Ines Vaide, 4209017

CLINICAL UTILITY OF ENDOGENOUS COLONY FORMATION ASSAY AND RISK OF THROMBOSIS IN MPNS

EHA Library, Danijela Lekovic, 4209018

IDENTIFICATION OF CLEC4E AS A FUNCTIONAL PATTERN RECOGNITION RECEPTOR MEDIATING Β-GLUCOSYLCERAMIDE–INDUCED PLATELET ACTIVATION VIA SYK SIGNALING

EHA Library, xuemei jia, 4209021

THREE-YEAR REAL-WORLD UTILIZATION OF ANDEXANET ALFA PRIOR TO U.S. MARKET WITHDRAWAL: AN 87-PATIENT CONSECUTIVE INSTITUTIONAL AUDIT (2022–2025)

EHA Library, Alifya Altaf Lokhandwala, 4209022

CLINICAL OUTCOMES ASSOCIATED WITH INAPPROPRIATE DIRECT ORAL ANTICOAGULANT PRESCRIBING IN A TERTIARY HOSPITAL

EHA Library, Nulee Yun, 4209023

ANTI-XA MEASUREMENTS IN THOSE WITH KIDNEY IMPAIRMENT IN A TERTIARY CENTRE

EHA Library, Gerard Gurumurthy, 4209024

HEALTH CARE UTILIZATION AND MANAGEMENT PATTERNS OF ASYMPTOMATIC INCIDENTAL PULMONARY EMBOLISM IN CANCER PATIENTS

EHA Library, Neha Agrawal*, 4209025

INTERPLAY OF NITRIC OXIDE AND INFLAMMATION IN THROMBOTIC EVENTS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Mirjana Mitrovic, 4209026

MONOCYTE-TO-RED CELL DISTRIBUTION WIDTH RATIO PREDICTS PULMONARY EMBOLISM IN PATIENTS WITH DEEP VEIN THROMBOSIS: A PROPENSITY SCORE–MATCHED ANALYSIS

EHA Library, Bulent Kantarciologu, 4209027

FUNCTIONAL ASPECTS OF FIBRIN STRUCTURE ALTERATIONS BY TRANEXAMIC ACID IN THE INHIBITION OF FIBRINOLYSIS

EHA Library, Nikolett Wohner, 4209028

INCIDENCE AND RISK FACTORS OF THROMBOSIS IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP): A MULTICENTER COHORT STUDY.

EHA Library, Maimoona Al Hinai, 4209029

INCIDENCE, PATIENT PROFILE, AND 3-MONTH SURVIVAL OF VENOUS THROMBOEMBOLISM IN INTERNAL MEDICINE INPATIENTS: A PILOT STUDY FROM TURKEY

EHA Library, Bulent Kantarciologu, 4209030

PATIENT-REPORTED FATIGUE AND IMPAIRED COGNITIVE FUNCTION AFTER ALLOGENEIC-HSCT: SIGNIFICANT CORRELATIONS WITH RETURN TO SOCIO-PROFESSIONAL ACTIVITIES – THE SOPRALLO STUDY

EHA Library, Yana Stepanishyna, 4209037

ASSOCIATIONS BETWEEN ECOG PERFORMANCE STATUS AND PATIENT-REPORTED OUTCOMES IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA: POST HOC ANALYSIS FROM THE ALPINE TRIAL

EHA Library, Nicole Lamanna, 4209043

CHANGES IN BODY COMPOSITION PARAMETERS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING INTENSIVE CHEMOTHERAPY PRIOR TO AN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Sofia Voigt, 4209044

MAINTENANCE OF HEALTH-RELATED QUALITY OF LIFE WITH VENETOCLAX-OBINUTUZUMAB VS CHEMOIMMUNOTHERAPY IN FIT PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA FROM THE PHASE 3 CRISTALLO TRIAL

EHA Library, Franck Morschhauser, 4209045

AQUALIS: AN OBSERVATIONAL QUALITY OF LIFE STUDY IN FRANCE ON PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED WITH ACALABRUTINIB:RAPID GAINS IN FUNCTION AND SYMPTOMS WITH HIGH ADHERENCE

EHA Library, Loic Ysebaert, 4209051

NURSING-LED SUPPORTIVE CARE, SYMPTOM BURDEN AND CAREGIVER OUTCOMES IN ACUTE MYELOID LEUKEMIA

EHA Library, Guijie Wu, 4209052

EFFECTIVENESS OF A MOTHER-CENTERED INFECTION PREVENTION (MCIP) EDUCATIONAL INTERVENTION IN REDUCING INFECTIONS AMONG PEDIATRIC ONCOLOGY PATIENTS: A RANDOMIZED CONTROLLED TRIAL

EHA Library, Ana Farooq, 4209053

RISK FACTOR ANALYSIS FOR MELPHALAN-RELATED ORAL MUCOSITIS IN ADULT HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS

EHA Library, Liya Ren, 4209057

HEMATOLOGIC MALIGNANCIES INCIDENTALLY DETECTED THROUGH CANCER SCREENING PROGRAM DURING 20 YEARS

EHA Library, Yuka Morita, 4209058

GLOBAL TRENDS OVER TWO DECADES IN CLINICAL TRIALS OF HEMATOLOGICAL MALIGNANCIES

EHA Library, Tarec El-Galaly, 4209061

BEYOND EFFICACY: TIME TOXICITY OF CAR-T VS BISPECIFIC ANTIBODIES IN MULTIPLE MYELOMA

EHA Library, Nadine Abdallah, 4209063

COST-EFFECTIVENESS ANALYSIS OF BREXUCABTAGENE AUTOLEUCEL IN ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKAEMIA IN SINGAPORE

EHA Library, Esther Hian Li Chan, 4209064

COST-EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL FOR TREATING TAIWANESE PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA AND HIGH-GRADE B-CELL LYMPHOMA AFTER FIRST-LINE TREATMENT

EHA Library, Bor-Sheng Ko, 4209065

REAL-WORLD IMPACT OF ATRIAL FIBRILLATION (AFIB) ON CARDIOVASCULAR (CV) OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Michael Fradley, 4209066

PATTERNS OF TREATMENT UTILIZATION AND SEQUENCING ACROSS LINES OF THERAPY IN WALDENSTRÖM MACROGLOBULINEMIA (WM): REAL-WORLD EVIDENCE FROM THE UNITED STATES

EHA Library, Prashant Kapoor, 4209067

COMPARISON OF THE COST OF MANAGING ADVERSE EVENTS WITH FIXED DURATION COMBINATION TARGETED THERAPY REGIMENS IN THE FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA IN BRAZIL

EHA Library, Ian Keary, 4209068

NANOPORE SEQUENCING AS A SINGLE-TEST DIAGNOSTIC PLATFORM FOR PEDIATRIC HEMATOLOGICAL MALIGNANCIES

EHA Library, Lennart A. Kester, 4209070

FHIR-FORMER: MATCHING LSTM PERFORMANCE IN PLATELET TRANSFUSION PREDICTION USING A LANGUAGE MODEL WITH ONE-TENTH THE TRAINING DATA

EHA Library, Merlin Engelke, 4209075

LYMPHKEY: AN INTEGRATIVE SOLUTION FOR THE MOLECULAR CHARACTERIZATION OF B- AND T-CELL MALIGNANCIES

EHA Library, Aleix Real, 4209077

TIER-BASED INTERPRETATION OF TARGETED NGS VARIANTS IN IDIOPATHIC ERYTHROCYTOSIS: INTEGRATING GENE–DISEASE VALIDITY AND STRUCTURAL MODELLING

EHA Library, Alessandra Giannella, 4209079

CLINICAL VALIDATION OF AN AI PLATFORM FOR BONE MARROW ASPIRATE DIFFERENTIAL COUNT: DIAGNOSTIC ACCURACY AND IMPACT OF EXPERT REVIEW.

EHA Library, Irene Zamanillo, 4209080

HIGH-SENSITIVITY PERIPHERAL BLOOD MEASURABLE RESIDUAL DISEASE DETECTION IN ACUTE MYELOID LEUKEMIA USING A MICROFLUIDIC RARE-CELL IMAGING IMMUNOPHENOTYPING PLATFORM

EHA Library, Ju-Yu Tseng, 4209081

HIGH RESOLUTION MAPPING OF IMMUNE CELL SURFACE PROTEIN INTERACTOMICS

EHA Library, Hanna van Ooijen, 4209082

REFINING THE INTERPRETATION AND REPORTING OF OPTICAL GENOME MAPPING DATA: RESULTS FROM TWO ROUNDS OF A SPANISH MULTICENTER INTERLABORATORY COMPARISON STUDY

EHA Library, Anna Puiggros, 4209083

INTRA-OPERATIVE HARVEST OF VIABLE HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS UNDERGOING CARDIAC SURGERY

EHA Library, Charlotte Lees, 4209084

EVALUATING THE DIAGNOSTIC POTENTIAL OF COMPREHENSIVE PLASMA CTDNA GENOMIC PROFILING IN AGGRESSIVE DLBCL

EHA Library, Zahra Haider, 4209085

HOSPITAL BURDEN OF CAR T INFUSION OF PATIENTS WITH FOLLICULAR LYMPHOMA OR MANTLE CELL LYMPHOMA IN FRANCE: A NATIONWIDE RETROSPECTIVE STUDY

EHA Library, Florian Colrat, 4208595

A DEEP LEARNING PET/CT BIOMARKER FOR EARLY PROGRESSION (POD24) AND SURVIVAL STRATIFICATION IN FOLLICULAR LYMPHOMA: A MULTICENTER STUDY

EHA Library, Chong Jiang, 4208597

PHASE 3 INMIND STUDY OF TAFASITAMAB (TAFA) PLUS LENALIDOMIDE (LEN) AND RITUXIMAB (R) FOR RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): OUTCOMES IN PATIENTS WITH OR WITHOUT HIGH-RISK FACTORS

EHA Library, Christian W. Scholz, 4208599

ZANUBRUTINIB PLUS RITUXIMAB AS FRONT-LINE TREATMENT FOR MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA: A SINGLE-ARM, PHASE II STUDY (ZAMA)

EHA Library, Qingqing Cai, 4208600

PRELIMINARY ANALYSIS OF ORELABRUTINIB COMBINED WITH OBINUTUZUMAB IN THE TREATMENT OF MARGINAL ZONE LYMPHOMA (ORION STUDY)

EHA Library, Rui Lv, 4208601

PRELIMINARY RESULTS OF ORELABRUTINIB FOLLOWED BY RESPONSE-ADAPTED ULTRA-LOW-DOSE 4GY RADIOTHERAPY AS FIRST-LINE TREATMENT FOR LOCALIZED MALT LYMPHOMA: A PROSPECTIVE, OPEN-LABEL, PHASE II STUDY

EHA Library, Yizhen Liu, 4208604

MANAGEMENT AND OUTCOMES OF FOLLICULAR LYMPHOMA (FL) WITH GASTROINTESTINAL (GI) INVOLVEMENT: SPANISH REAL WORLD EXPERIENCE FROM GELTAMO GROUP

EHA Library, Ma Jimena Cannata-Ortiz, 4208606

PHASE 1 FIRST-IN-HUMAN STUDY OF AUR112, A HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED LYMPHOID MALIGNANCIES

EHA Library, Suchit Kumbhare, 4208607

CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS WITH FOLLICULAR LYMPHOMA MANAGED WITH LONG-TERM INITIAL WATCH-AND-WAIT: A DANISH NATIONWIDE POPULATION-BASED STUDY

EHA Library, Ruth Salim Raaschou, 4208608

MACHINE LEARNING-BASED BODY COMPOSITION ANALYSIS FOR RISK STRATIFICATION IN MANTLE CELL LYMPHOMA (MCL) WITH NEED FOR SYSTEMIC TREATMENT

EHA Library, Marie-Kristin Tilch, 4208609

EFFICACY AND SAFETY OF NEMTABRUTINIB IN RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA: COHORT F OF THE PHASE 2 BELLWAVE-003 STUDY

EHA Library, Alessandra Tucci, 4208610

LONG TERM FOLLOW-UP OF THE FIRST REAL-LIFE SERIES OF OBINUTUZUMAB-CHEMOTHERAPY COMBINATIONS IN FRONT-LINE TREATMENT OF FOLLICULAR LYMPHOMA: A STUDY OF KROHEM

EHA Library, Sandra Bašić Kinda, 4208611

FIRST IN HUMAN STUDY OF CT1190B, AN ALLOGENEIC ANTI-CD19/CD20 CAR T-CELL THERAPY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Shiguang Ye, 4208615

RADIOTHERAPY AS BRIDGING, SALVAGE OR CONSOLIDATION STRATEGY IN CAR-T–TREATED LYMPHOMA PATIENTS: INSIGHTS FROM THE FRENCH DESCAR-T REGISTRY

EHA Library, Vincent Camus, 4208617

THE PIVOTAL CLINICAL STUDY OF IM19 CAR-T CELLS IN THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMAS

EHA Library, Yan Xie, 4208618

INTEGRATING VAF AND IMMUNE-COLLAGEN SUBTYPES IDENTIFIES A HIGH-RISK “SOFT” SUBTYPE IN TP53-MUTANT DLBCL WITH PRIMARY DOXORUBICIN RESISTANCE

EHA Library, Jinhua Liang, 4208620

EPCORITAMAB + CHEMOIMMUNOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT: POOLED RESULTS FROM ARMS 4 AND 10 OF EPCORE NHL-2

EHA Library, Raul Cordoba, 4208621

FC-GAMMA-RIIA-MEDIATED PROCOAGULANT PLATELETS ARE IMPORTANT DRIVERS OF IMMUNOTHROMBOSIS IN APS

EHA Library, Günalp Uzun, 4209019

PREDICTIVE ROLE OF ENDOTHELIAL-DERIVED EXTRACELLULAR VESICLES IN RECURRENT VENOUS THROMBOEMBOLISMPREDICTIVE ROLE OF ENDOTHELIAL-DERIVED EXTRACELLULAR VESICLES IN RECURRENT VENOUS THROMBOEMBOLISM

EHA Library, Aashal Shah, 4209020

PLATELET HYPERREACTIVITY OVERRIDES THROMBIN DYSREGULATION AS THE MAIN THROMBOTIC DRIVER IN AFIBRINOGENEMIA WITH A NOVEL FGA MUTATION (P.TRP248*)

EHA Library, Xiao Shuai, 4209031

SYK Y342 AND Y346 PHOSPHORYLATION IS ESSENTIAL FOR OPTIMAL ITAM AND HEMITAM-MEDIATED SIGNALING IN PLATELETS

EHA Library, Satya Kunapuli, 4209032

THROMBOTIC COMPLICATIONS AS PREDICTORS OF MORTALITY IN PEDIATRIC ECMO UNDER UNFRACTIONATED HEPARIN

EHA Library, Bader Allahyani, 4209033

A DIAGNOSTIC SAFETY GAP IN THROMBOPHILIA TESTING: UNRELIABLE TIMING AND DOWNSTREAM HARM

EHA Library, abdulrahman al raizah, 4209034

COMBINATION OF THROMBOPOIETIN RECEPTOR AGONISTS AND RITUXIMAB IN RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

EHA Library, Hong Tian, 4209035

ICANS AFTER CAR-T THERAPY: PERSISTENT COGNITIVE BUT NOT PSYCHIATRIC RISK - A PROPENSITY SCORE-MATCHED ANALYSIS

EHA Library, Heidi Cho, 4209036

VTE RISK ASSESSMENT MODELS (RAM), THROMBOPROPHYLAXIS USE & OUTCOMES IN ATOMM: ANTICOAGULATION FOR THROMBOSIS PREVENTION IN MULTIPLE MYELOMA, A LARGE REAL-WORLD COHORT OF NEWLY DIAGNOSED MYELOMA (NDMM)

EHA Library, Marquita Camilleri, 4209038

NEONATAL AND INFANT OUTCOMES FOLLOWING PREGNANCY-ASSOCIATED HAEMATOLOGICAL MALIGNANCIES: AN OBSERVATIONAL NATIONWIDE COHORT STUDY.

EHA Library, Justine De Croocq, 4209039

QUALITY OF LIFE AND CARE ORGANIZATION OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA WITHIN THE LOMBARDY HEMATOLOGY NETWORK: THE CML-OPERAP STUDY

EHA Library, Giacomo Mossini, 4209040

WHEN IS IT ENOUGH? REAL-WORLD END-OF-LIFE CARE PATTERNS IN HEMATOLOGIC MALIGNANCIES: THE NEED FOR PALLIATIVE CARE INTEGRATION.

EHA Library, Carmen Dbouk Y Jaudenes, 4209041

SUBCUTANEOUS DARATUMUMAB AT HOME IS A SAFE AND EFFECTIVE PROCEDURE ALLOWING ACTIVE TREATMENT OF FRAIL PATIENTS WITH MULTIPLE MYELOMA IN DIFFERENT GEOGRAPHICAL AREAS

EHA Library, Gioia De Angelis, 4209042

PRESCRIBING PRACTICE, RISK ASSESSMENT MODEL (RAM) USE, AND PERCEIVED GUIDELINE GAPS IN VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): UK NATIONAL SURVEY RESULTS

EHA Library, Marquita Camilleri, 4209046

WORKLOAD AND BURNOUT AMONG HEMATOLOGISTS IN THE COMMUNITY OF MADRID (SPAIN): KEY FINDINGS OF THE 2024–2027 STRATEGIC PLAN OF THE MADRID ASSOCIATION OF HEMATOLOGY AND HEMOTHERAPY

EHA Library, Adrian Alegre Amor, 4209047

EPCORITAMAB PLUS LENALIDOMIDE AND RITUXIMAB IMPROVES OR PRESERVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA WHO HAD HIGH SYMPTOM BURDEN OR ADVERSE EVENTS

EHA Library, Loic Ysebaert, 4209048

QOL-BLINA PROTOCOL OF AIEOP STUDY GROUP: PRELIMINARY DATA ON QOL AND PSYCHOSOCIAL RISK IN PATIENTS AND CAREGIVERS.

EHA Library, Fara Petruzziello, 4209049

BURDEN OF DISEASE MANAGEMENT AMONG PATIENTS WITH MULTIPLE MYELOMA AND THEIR CARE PARTNERS

EHA Library, Robin Tuohy, 4209050

SEXUAL HEALTH IN ADOLESCENTS AND YOUNG ADULTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANT – AN OVERLOOKED DIMENSION OF SURVIVORSHIP

EHA Library, Brittany Kimball, 4209054

LONGITUDINAL PATIENT-REPORTED OUTCOMES HIGHLIGHT IMPROVED QUALITY OF LIFE FOR R-CHOP-INELIGIBLE PATIENTS WITH AGGRESSIVE B-CELL LYMPHOMAS TREATED WITHIN THE FRONTLINE PHASE II R-POLA-GLO TRIAL

EHA Library, Rebecca Wurm-Kuczera, 4209055

GLOBAL PERSPECTIVES ON ACCESS TO CARE IN MYELODYSPLASTIC SYNDROMES: INSIGHTS FROM THE MDS GLOBAL ALLIANCE SURVEY 2024

EHA Library, Blerina Ahmetaj-Shala, 4209056

LIVING WITH ESSENTIAL THROMBOCYTHEMIA AND THE BROADER ECONOMIC CONSEQUENCES

EHA Library, Stina Salomonsson, 4209059

OUTPATIENT CAR T-CELL THERAPY ADMINISTRATION IMPACT ON HEALTHCARE UTILIZATION IN LYMPHOMA PATIENTS

EHA Library, Susanna Bowen, 4209060

FEASIBILITY AND ECONOMIC EVALUATION FOR HOSPITAL-AT-HOME INFUSION OF  CARFILZOMIB IN THE MANAGEMENT OF MULTIPLE MYELOMA (CARFIL‑HAD STUDY)

EHA Library, Mohamed Touati, 4209062

INCIDENCE AND SURVIVAL OF HEMATOLOGICAL NEOPLASIAS IN THE COMMUNITY OF MADRID (SPAIN) FROM 2014 TO 2024: BURDEN, TEMPORAL IMPROVEMENT, AND CARE HOMOGENEITY

EHA Library, JOSE ANGEL HERNANDEZ RIVAS, 4209069

PREDICTING RESPONSE TO INITIAL ANTHRACYCLINE-BASED CHEMOTHERAPY AND PROGNOSIS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA USING A CLINICAL-MOLECULAR INTEGRATED LARGE REASONING MODEL

EHA Library, Sai Huang, 4209071

DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING-BASED DIAGNOSTIC MODEL FOR BONE MARROW CELL MORPHOLOGY IN MALIGNANT HEMATOLOGICAL DISEASES: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Tinglu Tao, 4209072

MACHINE LEARNING AND MECHANISTIC MODELLING-BASED RECONSTRUCTION OF HEMATOPOIETIC TRAJECTORIES BY CSTAR REVEALS NOVEL LEUKEMIA DIFFERENTIATION STRATEGIES

EHA Library, Ciardha Carmody, 4209073

SELF-SUPERVISED VISION TRANSFORMER WITH UNCERTAINTY-AWARE CALIBRATION FOR AUTOMATED ACUTE LYMPHOBLASTIC LEUKEMIA SCREENING IN PERIPHERAL BLOOD SMEARS

EHA Library, Fatemeh Mohammadsadeghi, 4209074

IMPROVED PREDICTION OF MYELOID MALIGNANCIES USING BAYESIAN JOINT MODELING ON POPULATION LEVEL LABORATORY DATA

EHA Library, Juuso Vedenjuoksu, 4209076

HIGH-THROUGHPUT CRISPR SCREENS UNCOVER SELECTIVE EZH2 INHIBITOR TAZEMETOSTAT DRIVES EXPANSION OF PRELEUKEMIC HEMATOPOIETIC STEM AND PROGENITOR CELLS WITH MUTATIONS IN ASXL1.

EHA Library, Ieva Budriunaite, 4209078